Inventaire - your friends and communities are your best library

Diversity and recognition efficiency of T cell responses to cancer

Author

Tor B. Stuge

Susan P. Holmes

1954 -

Published in: PLOS MEDICINE

Date of publication: November 2004

Language: English

Bibliographic databases:

Cites articles 42

Date

Title

Authors

September 1, 1993

Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
January 1, 1997

Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A
March 1, 1998

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
February 1, 1998

Massive expansion of antigen-specific CD8+ T cells during an acute virus infection
February 1, 1998

Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues

,
August 1, 1998

Termination of peripheral tolerance to a T cell epitope by heteroclitic antigen analogues
October 1, 1998

Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination
October 1, 1999

The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope
September 1, 1999

An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions

, , , ,
February 1, 1999

Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers
January 1, 1999

High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy

,
June 1, 1999

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
February 1, 1999

Changes in the fine specificity of gp100(209-217)-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residue
July 1, 1999

Antitumor immunization with a minimal peptide epitope (G9-209-2M) leads to a functionally heterogeneous CTL response
December 1, 1999

Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression
September 1, 2001

Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma
August 21, 2001

Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life
August 21, 2001

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.
June 26, 2001

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
May 1, 2001

Progress in human tumour immunology and immunotherapy
February 1, 2001

Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen
December 3, 2001

T cells down-modulate peptide-MHC complexes on APCs in vivo.

, , ,
July 1, 2001

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.
June 1, 2001

Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining
August 1, 2001

TCR avidity: it's not how strong you make it, it's how you make it strong
August 1, 2001

Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity
August 1, 2001

Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR
May 1, 2001

Kinetics of TCR use in response to repeated epitope-specific immunization
November 11, 2002

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells
October 1, 2002

Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings

, , , , , , ,
May 1, 2002

Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection

, ,
February 1, 2002

Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR

Article -

Welcome to inventaire

The library of your friends and communities

Learn more